Total Payments
$7,393
2024 Payments
$1,279
Companies
42
Transactions
423
Medicare Patients
5,758
Medicare Billing
$548,762
Payment Breakdown by Category
Food & Beverage$7,102 (96.1%)
Education$291.02 (3.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,102 | 415 | 96.1% |
| Education | $291.02 | 8 | 3.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $1,621 | 98 | $0 (2024) |
| ViiV Healthcare Company | $1,204 | 69 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $756.58 | 47 | $0 (2023) |
| Novo Nordisk Inc | $556.72 | 40 | $0 (2024) |
| Lilly USA, LLC | $381.25 | 23 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $267.92 | 16 | $0 (2024) |
| Janssen Products, LP | $258.95 | 3 | $0 (2022) |
| PFIZER INC. | $258.05 | 16 | $0 (2024) |
| Amgen Inc. | $227.15 | 12 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $182.22 | 13 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,279 | 64 | ViiV Healthcare Company ($522.60) |
| 2023 | $1,001 | 62 | Gilead Sciences, Inc. ($376.45) |
| 2022 | $1,444 | 86 | Takeda Pharmaceuticals U.S.A., Inc. ($453.41) |
| 2021 | $1,624 | 91 | Gilead Sciences, Inc. ($221.99) |
| 2020 | $1,211 | 67 | Lilly USA, LLC ($137.57) |
| 2019 | $278.35 | 22 | Gilead Sciences, Inc. ($121.34) |
| 2018 | $265.14 | 13 | AstraZeneca Pharmaceuticals LP ($77.00) |
| 2017 | $291.39 | 18 | Janssen Products, LP ($99.95) |
All Payment Transactions
423 individual payment records from CMS Open Payments — Page 2 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/14/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $6.74 | General |
| 08/07/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $28.85 | General |
| Category: HIV | ||||||
| 07/31/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $25.80 | General |
| Category: HIV | ||||||
| 07/24/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: HIV | ||||||
| 07/17/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $31.14 | General |
| 07/10/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $7.88 | General |
| 07/03/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $27.83 | General |
| Category: HIV | ||||||
| 06/26/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $24.54 | General |
| Category: Obesity | ||||||
| 06/24/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $9.73 | General |
| Category: Diabetes | ||||||
| 06/19/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $24.36 | General |
| Category: HIV | ||||||
| 06/15/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.45 | General |
| 06/14/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $3.23 | General |
| 06/05/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $31.63 | General |
| 05/29/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $26.96 | General |
| Category: HIV | ||||||
| 05/15/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $28.05 | General |
| Category: HIV | ||||||
| 05/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $7.20 | General |
| Category: Diabetes | ||||||
| 05/01/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $30.12 | General |
| 04/29/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $5.68 | General |
| 04/25/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: HIV | ||||||
| 04/18/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $33.70 | General |
| 04/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $6.98 | General |
| Category: Diabetes | ||||||
| 04/03/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: HIV | ||||||
| 03/27/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $22.71 | General |
| Category: HIV | ||||||
| 03/27/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $5.75 | General |
| Category: HIV | ||||||
| 03/27/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $2.09 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 1,609 | 3,098 | $282,330 | $166,725 |
| 2022 | 10 | 1,517 | 2,739 | $249,710 | $148,458 |
| 2021 | 8 | 1,330 | 2,048 | $211,440 | $126,550 |
| 2020 | 8 | 1,302 | 1,996 | $197,255 | $107,029 |
Total Patients
5,758
Total Services
9,881
Medicare Billing
$548,762
Procedure Codes
37
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 488 | 1,127 | $185,955 | $96,419 | 51.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 268 | 268 | $33,500 | $33,599 | 100.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 546 | 1,167 | $11,670 | $9,719 | 83.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 108 | 131 | $14,410 | $8,615 | 59.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 20 | 97 | $7,275 | $3,877 | 53.3% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 22 | 22 | $3,850 | $3,643 | 94.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 32 | 32 | $8,800 | $3,399 | 38.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 22 | 23 | $6,325 | $3,042 | 48.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 15 | 15 | $5,100 | $2,217 | 43.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 17 | 141 | $2,820 | $1,437 | 51.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 71 | 75 | $2,625 | $756.46 | 28.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 461 | 1,035 | $170,775 | $89,483 | 52.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 311 | 311 | $38,875 | $38,906 | 100.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 76 | 89 | $9,790 | $5,437 | 55.5% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 22 | 22 | $3,850 | $3,688 | 95.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 515 | 1,037 | $10,370 | $3,033 | 29.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 25 | 25 | $6,875 | $2,957 | 43.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 17 | 44 | $3,300 | $1,988 | 60.2% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 29 | 30 | $2,250 | $1,454 | 64.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 16 | 99 | $1,980 | $1,053 | 53.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 45 | 47 | $1,645 | $458.54 | 27.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 446 | 879 | $145,035 | $77,711 | 53.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 255 | 255 | $31,875 | $32,311 | 101.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 80 | 90 | $9,900 | $5,672 | 57.3% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2021 | 22 | 22 | $3,850 | $3,733 | 96.9% |
About Dr. Kush Patel, MD
Dr. Kush Patel, MD is a Internal Medicine healthcare provider based in Largo, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/13/2005. The National Provider Identifier (NPI) number assigned to this provider is 1922006865.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kush Patel, MD has received a total of $7,393 in payments from pharmaceutical and medical device companies, with $1,279 received in 2024. These payments were reported across 423 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($7,102).
As a Medicare-enrolled provider, Patel has provided services to 5,758 Medicare beneficiaries, totaling 9,881 services with total Medicare billing of $548,762. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Largo, FL
- Active Since 07/13/2005
- Last Updated 06/04/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1922006865
Products in Payments
- APRETUDE (Biological) $670.36
- TRINTELLIX (Drug) $637.26
- Ozempic (Drug) $290.57
- CABENUVA (Biological) $286.43
- DOVATO (Drug) $246.81
- FARXIGA (Drug) $244.10
- EMGALITY (Drug) $167.11
- PREZCOBIX (Drug) $159.95
- SYMTUZA (Drug) $159.72
- Rybelsus (Drug) $138.86
- Vascepa (Drug) $129.88
- EYLEA (Biological) $125.00
- TRULICITY (Drug) $112.62
- XARELTO (Drug) $110.00
- VYVANSE (Drug) $108.25
- EVENITY (Biological) $100.82
- XIFAXAN (Drug) $99.56
- Dayvigo (Drug) $94.42
- JARDIANCE (Drug) $89.40
- Wegovy (Drug) $89.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Largo
Dr. Brian Lake, D.o, D.O
Internal Medicine — Payments: $1.1M
Internal Medicine $1.1M
Dr. Eduardo Martinez, Md, MD
Internal Medicine — Payments: $19,139
Internal Medicine $19,139
Rakhee Shah, D.o, D.O
Internal Medicine — Payments: $18,119
Internal Medicine $18,119
Randal Worth, Do, DO
Internal Medicine — Payments: $15,659
Internal Medicine $15,659
Vlad Badescu, Md, MD
Internal Medicine — Payments: $14,612
Internal Medicine $14,612
Jennifer Kudelko, D.o, D.O
Internal Medicine — Payments: $14,033
Internal Medicine $14,033